Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 2 | 2023 | 476 | 0.240 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 315 | 0.180 |
Why?
|
| Bacterial Infections | 1 | 2023 | 305 | 0.180 |
Why?
|
| Naphthalenes | 1 | 2019 | 37 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 155 | 0.170 |
Why?
|
| Patient Safety | 1 | 2024 | 397 | 0.160 |
Why?
|
| Bacteremia | 1 | 2023 | 405 | 0.160 |
Why?
|
| Quality Improvement | 1 | 2024 | 625 | 0.150 |
Why?
|
| Eating | 1 | 2019 | 373 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 230 | 0.140 |
Why?
|
| Cardiac Catheterization | 1 | 2020 | 630 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2020 | 580 | 0.130 |
Why?
|
| Thrombosis | 1 | 2020 | 518 | 0.130 |
Why?
|
| Simplexvirus | 1 | 2014 | 104 | 0.120 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 41 | 0.120 |
Why?
|
| Herpes Simplex | 1 | 2014 | 56 | 0.110 |
Why?
|
| Lactoferrin | 1 | 2013 | 77 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2014 | 236 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 266 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 239 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 439 | 0.090 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8114 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2014 | 807 | 0.080 |
Why?
|
| Receptors, Purinergic | 1 | 2023 | 16 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2023 | 17 | 0.060 |
Why?
|
| Organizational Culture | 1 | 2024 | 94 | 0.050 |
Why?
|
| Nucleotides | 1 | 2023 | 93 | 0.050 |
Why?
|
| Safety Management | 1 | 2024 | 111 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2024 | 206 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 293 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 331 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 663 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2023 | 792 | 0.040 |
Why?
|
| Anemia, Hemolytic | 1 | 2019 | 30 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 1282 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1253 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 1742 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 3725 | 0.030 |
Why?
|
| Acyclovir | 1 | 2014 | 45 | 0.030 |
Why?
|
| Pregnancy | 2 | 2019 | 7129 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2014 | 55 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4367 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2013 | 81 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2014 | 435 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 17547 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12169 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4701 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1687 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1236 | 0.020 |
Why?
|
| Placenta | 1 | 2014 | 491 | 0.020 |
Why?
|
| Gestational Age | 1 | 2014 | 1137 | 0.020 |
Why?
|
| Humans | 5 | 2024 | 123258 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2014 | 744 | 0.020 |
Why?
|
| United States | 1 | 2024 | 10652 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1084 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 33842 | 0.020 |
Why?
|
| Female | 3 | 2020 | 65619 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 12376 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16068 | 0.010 |
Why?
|
| Male | 2 | 2020 | 60337 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 8868 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 29100 | 0.010 |
Why?
|